共 54 条
[1]
Modlin IM(2008)Gastroenteropancreatic neuroendocrine tumours Lancet Oncol 9 61-72
[2]
Sundin A(2012)Radiological and nuclear medicine imaging of gastroenteropancreatic neuroendocrine tumours Best Pract Res Clin Gastroenterol 26 803-18
[3]
Bodei L(2009)Peptide receptor therapies in neuroendocrine tumors J Endocrinol Investig 32 360-9
[4]
Gabriel M(2007)68Ga-DOTA-Tyr3-Octreotide PET in neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and CT J Nucl Med 48 508-18
[5]
Koopmans KP(2008)Improved staging of patients with carcinoid and islet cell tumors with 18 F-dihydroxy-phenyl-alanine and 11C-5-hydroxy-tryptophan positron emission tomography J Clin Oncol 26 1489-95
[6]
Orlefors H(2005)Whole-body (11)C-5-hydroxytryptophan positron emission tomography as a universal imaging technique for neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and computed tomography J Clin Endocrinol Metab 90 3392-400
[7]
Baum RP(2012)Peptides and receptors in image-guided therapy: theranostics for neuroendocrine neoplasms Semin Nucl Med 42 190-207
[8]
Kulkarni HR(2008)Comparison between 68Ga-DOTA-NOC and 18F-DOPA PET for the detection of gastro-entero-pancreatic and lung neuro-endocrine tumours Eur J Nucl Med Mol Imaging 35 1431-8
[9]
Carreras C(2009)Intraindividual comparison of 68Ga-DOTA-TATE and 18F-DOPA PET in patients with well-differentiated metastatic neuroendocrine tumours Eur J Nucl Med Mol Imaging 36 765-70
[10]
Ambrosini V(2010)68Ga-DOTANOC PET/CT clinical impact in patients with neuroendocrine tumors J Nucl Med 51 669-73